Despite the strong earnings outlook and growth expected to o...

Despite the strong earnings outlook and growth expected to outpace the market, Shanghai Runda Medical Technology’s P/E is below most other companies, suggesting shareholders may be doubtful of the forecasts or anticipating earnings instability.